Publications

Communications

 
  Search All Categories
 |  

Invitations [ 4 ]

Type
Doc#
Title
Version
SubVersion
PublishDate
Size
Select
9.107Medical Device Workshop with IndustryV131-Jan-201835 KB
9.110Meeting of CEOs of Complementary Medicines with Board of SAHPRAV109-May-201875 KB
9.91Workshop on clinical trials related mattersV111-Oct-201761 KB
9.98Meeting between CEOs and Chairperson of MCC and RegistrarV102-Aug-201758 KB

Medical Devices [ 3 ]

Type
Doc#
Title
Version
SubVersion
PublishDate
Size
Select
9.105Section 21 authorisation of sale of unregistered medical devicesV129-Dec-201737 KB
9.106Position Statement: Class A Medical DevicesV129-Dec-201741 KB
9.79Medical Device Establishments: Licence RequirementsV120-Sep-201634 KB

Press releases [ 1 ]

Type
Doc#
Title
Version
SubVersion
PublishDate
Size
Select
10.15Press release – Use of Dolutegravir in PregnancyV123-May-201886 KB

Scheduling [ 9 ]

Type
Doc#
Title
Version
SubVersion
PublishDate
Size
Select
9.104Scheduling matters: Rescheduling of atovaquone & proguanilV118-Dec-201738 KB
9.61Scheduling of aspirinV211-Mar-201642 KB
9.68Scheduling of ibogaineV111-Mar-201641 KB
9.69Rescheduling of DiclofenacV207-Oct-201644 KB
9.73Rescheduling of epehdrine, ephedra alkaloids & phenylpropanolamineV207-Oct-201647 KB

[ 57 ]

Type
Doc#
Title
Version
SubVersion
PublishDate
Size
Select
10.07Press release – withdrawal of rosiglitazoneV111-Jul-20117 KB
10.08Press release – on dextropropoxypheneV124-Nov-2011148 KB
10.09Press release – cough and cold medicinesV101-Jun-201232 KB
10.10Press release – CAMSV113-Jan-201438 KB
10.11Press release ARV fixed dose pre-exposure prophylaxisV108-Dec-201552 KB
10.12Media Release – MCC warns against use of unregistered medicine Miracle Mineral SolutionV118-May-201643 KB
10.13Press release : Medicines Control Council alerts the public of the risks and harm associated with the inappropriate and non-prescribed use of testosterone-containing medicinesV111-Aug-201642 KB
10.14Press Release: Medicines Control Council clarifies access to Cannabis for the treatment of medical conditionsV126-Nov-2016163 KB
10.15Media Release: Appointment of SAHPRA BoardV125-Oct-201746 KB
9.08Process for handling healthcare professional letters relating to safety and medicine safety alertsV303-Mar-201555 KB
9.100Use of Indian WalnutV102-Oct-201739 KB
9.101Communication with Council and CommitteesV102-Oct-201734 KB
9.102Appointment of Quality and Bioequivalence EvaluatorsV118-Oct-201738 KB
9.103Tissue Engineering ProductsV118-Dec-201738 KB
9.108Meeting between CEOs and Chairperson of SAHPRA BoardV110-Mar-201875 KB
9.13USRNV130-Jun-2015143 KB
9.17Expert Committees Meeting Dates for 2018V407-Feb-201844 KB
9.22Malaria prophylaxisV109-Mar-2009206 KB
9.25EnoxaparinV103-Aug-200987 KB
9.28Cancellation or withdrawalV101-Sep-200982 KB